Updated mapping system launched for complex arrhythmias
Click Here to Manage Email Alerts
Biosense Webster announced the launch of a heart mapping system and mapping module for use in patients with complex arrhythmias.
When used together, the 3D heart mapping system (Carto 3) and the mapping module (Carto Prime) can potentially significantly reduce ablation times when compared with standard mapping algorithms, according to a press release from the company.
The mapping model has several tools such as the technology (coherent mapping) to diagnose scar complex atrial arrhythmias related to scarring by placing constraints on local activation times information, according to the release. Technology (Cartofinder) also allows the mapping system to identify irregular atrial arrhythmia through the assessment of repetitive focal and rotational activations. The model can also perform simultaneous mapping of different arrhythmias (parallel mapping) through the same catheter locations.
“Carto Prime is the most important software release since the introduction of Carto 3,” Elad Anter, MD, associate section head of electrophysiology at Cleveland Clinic, said in the release. “Coherent mapping helps to overcome many of the challenges in electro-anatomical mapping of complex arrhythmias, and with parallel mapping, we’re able to map different rhythms simultaneously.”
Another capability (LAT hybrid) can provide electrophysiologists increased location accuracy by linking the premature ventricular complex map local activation time information with a normal sinus rhythm location, according to the release.
“This technology has a full package of [electrophysiology] mapping solutions to help get clear and accurate visualizations of almost every type of complex arrhythmia,” Vias Markides, MD, consultant cardiologist and director of the heart division at Royal Brompton Hospital in London, said in the release. “Features like Cartofinder, LAT hybrid and parallel mapping are significant improvements in mapping capabilities and make this a transformative step in technology.”
“The launch of Carto 3 system version 7 and the Carto Prime mapping module reflects our collaborative efforts with physicians to identify pressing clinical needs and then integrate innovative technologies into our platform to address them,” Uri Yaron, worldwide president of Biosense Webster, said in the release. “This release benefits patients and the [electrophysiology] community by helping us make the complex simple.”